Skip to main content
×
Home
    • Aa
    • Aa

THE EVIDENCE FOR LATE-ONSET PRE-ECLAMPSIA AS A MATERNOGENIC DISEASE OF PREGNANCY

  • ENRICO FERRAZZI (a1), TAMARA STAMPALIJA (a1) and JEAN EDGARD AUPONT (a2)
Abstract

It is our opinion that the evidence from epidemiological observations, clinical trials and biological studies is strong enough to support the view of different origin and phenotypes of pre-eclampsia: placental, which usually occurs (but not exclusively) early in pregnancy and is associated with poor early placentation of different severity with subsequent restriction of foetal growth, at different stages of gestation; and maternogenic, which generally occurs late in pregnancy and it is not related to placental insufficiency and foetal growth restriction.

Copyright
Corresponding author
Enrico Ferrazzi, Department of Woman, Mother and Neonate, Buzzi Children's Hospital, University Department of Biological and Clinical Sciences, University of Milan, Milan, Italy. Email: enrico.ferrazzi@unimi.it
References
Hide All
1Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33 (3): 130–37. Epub 2009/05/26.
2Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367 (9516): 1066–74. Epub 2006/04/04.
3Zhang C, Ning Y. Effect of dietary and lifestyle factors on the risk of gestational diabetes: review of epidemiologic evidence. Am J Clin Nutrit 2011; 94 (6 Suppl): 1975S9S. Epub 2011/05/27.
4Bell MJ. A historical overview of preeclampsia–eclampsia. J Obstet Gynecol Neonatal Nurs: JOGNN/NAACOG 2010; 39 (5):510–18. Epub 2010/10/06.
5Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2011; 25 (4): 391403. Epub 2011/02/22.
6Steegers AE, von Dadelszen P, Duvekot JJ, Pijnenborg R. Seminar, Preeclampsia. Lancet 2010; 376: 631–44.
7Sibai BM. Preeclampsia as a cause of preterm and late preterm (near-term) births. Semin Perinatol 2006; 30 (1): 1619. Epub 2006/03/22.
8Magee LA, Helewa M, Moutquin JM, von Dadelszen P. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. SOGC clinical Practice Guideline, No. 206, March 2008. JOGC 2008; 30 (Suppl 1): S1S48.
9Burton GJ, Woods AW, Jauniaux E, Kingdom JC. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 2009; 30 (6): 473–82. Epub 2009/04/21.
10Borzychowski AM, Sargent IL, Redman CW. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med. 2006; 11 (5): 309–16. Epub 2006/07/11.
11Long PA, Abell DA, Beischer NA. Fetal growth retardation and pre-eclampsia. Br J Obstet Gynaecol 1980; 87 (1): 1318. Epub 1980/01/01.
12Ferrazzi E, Rigano S, Padoan A, Boito S, Pennati G, Galan HL. Uterine artery blood flow volume in pregnant women with an abnormal pulsatility index of the uterine arteries delivering normal or intrauterine growth restricted newborns. Placenta 2011; 32 (7): 487–92. Epub 2011/05/03.
13Ferrazzi E, Bulfamante G, Mezzopane R, Barbera A, Ghidini A, Pardi G. Uterine Doppler velocimetry and placental hypoxic-ischemic lesion in pregnancies with fetal intrauterine growth restriction. Placenta 1999; 20 (56): 389–94. Epub 1999/07/27.
14Alfirevic Z, Stampalija T, Gyte GM. Fetal and umbilical Doppler ultrasound in high-risk pregnancies. Cochrane Database Syst Rev 2010; (1): CD007529. Epub 2010/01/22.
15Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD. Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG 2006; 113 (5): 580–89. Epub 2006/04/04.
16Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B. The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol. 2003; 189 (4): 1173–77. Epub 2003/10/31.
17Vadillo-Ortega F, Perichart-Perera O, Espino S, Avila-Vergara MA, Ibarra I, Ahued R, et al.Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high-risk population: randomised controlled trial. BMJ 2011; 342: d2901. Epub 2011/05/21.
18Martinelli I, Ruggenenti P, Cetin I, Pardi G, Perna A, Vergani P, et al.Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial. Blood 2012; 119 (14): 3269–75. Epub 2012/02/01.
19Gris JC, Chauleur C, Molinari N, Mares P, Fabbro-Peray P, Quere I, et al.Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomised controlled NOH-PE trial. Thromb Haemost 2011; 106 (6): 1053–61. Epub 2011/09/29.
20Conserva V, Muggiasca M, Arrigoni L, Mantegazza V, Rossi E, Ferrazzi E. Recurrence and severity of abnormal pregnancy outcome in patients treated by low-molecular-weight heparin: a prospective pilot study. J Matern Fetal Neonatal Med 2012; 25 (8): 1467–73. Epub 2011/11/30.
21Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998; 179 (1): 80–6. Epub 1998/08/15.
22Smarason AK, Gunnarsson A, Alfredsson JH, Valdimarsson H. Monocytosis and monocytic infiltration of decidua in early pregnancy. J Clin Lab Immunol 1986; 21 (1): 15. Epub 1986/09/01.
23Austgulen R, Lien E, Liabakk NB, Jacobsen G, Arntzen KJ. Increased levels of cytokines and cytokine activity modifiers in normal pregnancy. Eur J Obstet Gynecol Reprod Biol 1994; 57 (3): 149–55. Epub 1994/12/01.
24Gatti L, Tenconi PM, Guarneri D, Bertulessi C, Ossola MW, Bosco P, et al.Hemostatic parameters and platelet activation by flow-cytometry in normal pregnancy: a longitudinal study. Int J Clin Lab Res 1994; 24 (4): 217–19. Epub 1994/01/01.
25Halligan A, Bonnar J, Sheppard B, Darling M, Walshe J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynaecol. 1994; 101 (6): 488–92. Epub 1994/06/01.
26Haram K, Augensen K, Elsayed S. Serum protein pattern in normal pregnancy with special reference to acute-phase reactants. Br J Obstet Gynaecol 1983; 90 (2): 139–45. Epub 1983/02/01.
27Studd JW, Blainey JD, Bailey DE. Serum protein changes in the pre-eclampsia–eclampsia syndrome. JObstet Gynaecol Br Commonw 1970; 77 (9): 796801. Epub 1970/09/01.
28Stanley K, Fraser R, Bruce C. Physiological changes in insulin resistance in human pregnancy: longitudinal study with the hyperinsulinaemic euglycaemic clamp technique. Br J Obstet Gynaecol 1998; 105 (7): 756–59. Epub 1998/08/06.
29Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al.Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111 (5): 649–58. Epub 2003/03/06.
30Lee SM, Romero R, Lee YJ, Park IS, Park CW, Yoon BH. Systemic inflammatory stimulation by microparticles derived from hypoxic trophoblast as a model for inflammatory response in preeclampsia. Am J Obstet Gynecol 2012; 207 (4): 337 e1–8. Epub 2012/10/02.
31WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization technical report series. 2000; 894: i–xii, 1–253. Epub 2001/03/10.
32Wood LE. Obesity, waist–hip ratio and hunter-gatherers. BJOG 2006; 113 (10): 1110–16. Epub 2006/09/16.
33Despres JP. Is visceral obesity the cause of the metabolic syndrome? Ann Med 2006; 38 (1): 5263. Epub 2006/02/02.
34Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006; 444 (7121): 847–53. Epub 2006/12/15.
35Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci 1999; 892: 146–54. Epub 2000/06/08.
36Cote M, Mauriege P, Bergeron J, Almeras N, Tremblay A, Lemieux I, et al.Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J Clin Endocrinol Metab 2005; 90 (3): 1434–39. Epub 2004/12/16.
37Suganami T, Nishida J, Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol. 2005; 25 (10): 2062–8. Epub 2005/08/27.
38Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW, Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112 (12):1796–808. Epub 2003/12/18.
39Curat CA, Miranville A, Sengenes C, Diehl M, Tonus C, Busse R, et al.From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 2004; 53 (5): 1285–92. Epub 2004/04/28.
40Cancello R, Clement K. Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG 2006; 113 (10): 1141–47. Epub 2006/08/15.
41Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al.Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112 (12): 1821–30. Epub 2003/12/18.
42Grundy SM, Brewer HB Jr., Cleeman JI, Smith SC Jr., Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004; 24 (2): e1318. Epub 2004/02/10.
43Sohlberg S, Stephansson O, Cnattingius S, Wikstrom AK. Maternal body mass index, height, and risks of preeclampsia. Am J Hypertens 2012; 25 (1): 120–25. Epub 2011/10/07.
44Crispi F, Llurba E, Dominguez C, Martin-Gallan P, Cabero L, Gratacos E. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 2008; 31 (3): 303–9. Epub 2007/12/07.
45Mbah AK, Kornosky JL, Kristensen S, August EM, Alio AP, Marty PJ, et al. Super-obesity and risk for early and late pre-eclampsia BJOG 2010 Jul; 117 (8): 9971004.
46Crispi F, Dominguez C, Llurba E, Martin-Gallan P, Cabero L, Gratacos E. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol 2006; 195 (1): 201–7. Epub 2006/03/21.
47Mayhew TM, Ohadike C, Baker PN, Crocker IP, Mitchell C, Ong SS. Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. Placenta 2003; 24 (23): 219–26. Epub 2003/02/05.
48Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension 2008; 52 (5): 873–80. Epub 2008/10/01.
49Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, et al.Host-gut microbiota metabolic interactions. Science 2012; 336 (6086): 1262–67. Epub 2012/06/08.
50Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science 2012; 336 (6086): 1268–73. Epub 2012/06/08.
51Brantsaeter AL, Myhre R, Haugen M, Myking S, Sengpiel V, Magnus P, et al.Intake of probiotic food and risk of preeclampsia in primiparous women: the Norwegian Mother and Child Cohort Study. Am J Epidemiol 2011; 174 (7): 807–15. Epub 2011/08/09.
52Maynard CL, Elson CO, Hatton RD, Weaver CT. Reciprocal interactions of the intestinal microbiota and immune system. Nature 2012; 489 (7415): 231–41. Epub 2012/09/14.
53Bergen NE, Jaddoe VW, Timmermans S, Hofman A, Lindemans J, Russcher H, et al.Homocysteine and folate concentrations in early pregnancy and the risk of adverse pregnancy outcomes: the Generation R Study. BJOG 2012; 119 (6): 739–51. Epub 2012/04/12.
54Lamkanfi M, Walle LV, Kanneganti TD. Deregulated inflammasome signaling in disease. Immunol Rev 2011; 243 (1): 163–73. Epub 2011/09/03.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Fetal and Maternal Medicine Review
  • ISSN: 0965-5395
  • EISSN: 1469-5065
  • URL: /core/journals/fetal-and-maternal-medicine-review
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 12 *
Loading metrics...

Abstract views

Total abstract views: 216 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 22nd October 2017. This data will be updated every 24 hours.